12:00 AM
Sep 17, 2012
 |  BC Week In Review  |  Company News  |  Deals

AmpliPhi BioSciences, Special Phage deal

AmpliPhi will acquire Special Phage in a stock deal under which AmpliPhi has offered up to 40 million shares to Special Phage. The shares are valued at up to $4.4 million based on AmpliPhi's Sept. 7...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >